Effect of ezetimibe add-on therapy over 52 weeks extension analysis of prospective randomized trial (RESEARCH study) in type 2 diabetes subjects
Sign Up to like & getrecommendations! Published in 2017 at "Lipids in Health and Disease"
DOI: 10.1186/s12944-017-0508-4
Abstract: BackgroundLowering cholesterol levels decreases the risk of atherosclerotic diseases. Effective ways to stably reduce LDL-C level are warranted in type 2 diabetic patients, a high-risk population for CVD, with various anti-diabetic therapeutic background. The RESEARCH… read more here.
Keywords: effect ezetimibe; ezetimibe add; add therapy; research study ... See more keywords